MetLife Investment Management’s Monopar Therapeutics MNPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$90.8K Buy
+2,538
New +$90.8K ﹤0.01% 2597